AU2003241675A1 - Medicinal cephem compound composition for injection - Google Patents
Medicinal cephem compound composition for injectionInfo
- Publication number
- AU2003241675A1 AU2003241675A1 AU2003241675A AU2003241675A AU2003241675A1 AU 2003241675 A1 AU2003241675 A1 AU 2003241675A1 AU 2003241675 A AU2003241675 A AU 2003241675A AU 2003241675 A AU2003241675 A AU 2003241675A AU 2003241675 A1 AU2003241675 A1 AU 2003241675A1
- Authority
- AU
- Australia
- Prior art keywords
- medicinal
- injection
- compound composition
- cephem compound
- cephem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- -1 cephem compound Chemical class 0.000 title 1
- 238000002347 injection Methods 0.000 title 1
- 239000007924 injection Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002181428 | 2002-06-21 | ||
| JP2002-181428 | 2002-06-21 | ||
| PCT/JP2003/007610 WO2004000323A1 (en) | 2002-06-21 | 2003-06-16 | Medicinal cephem compound composition for injection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003241675A1 true AU2003241675A1 (en) | 2004-01-06 |
Family
ID=29996628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003241675A Abandoned AU2003241675A1 (en) | 2002-06-21 | 2003-06-16 | Medicinal cephem compound composition for injection |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003241675A1 (en) |
| WO (1) | WO2004000323A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1656930A1 (en) * | 2004-11-10 | 2006-05-17 | Basilea Pharmaceutica AG | Stabilized freeze-dried formulation for cephalosporin derivatives |
| MX2010009628A (en) * | 2008-03-04 | 2010-09-28 | Elan Pharma Int Ltd | Stable liquid formulations of anti-infective agents and adjusted anti-infective agent dosing regimens. |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6045514A (en) * | 1983-08-22 | 1985-03-12 | Shionogi & Co Ltd | Stable antibacterial lyophilized pharmactical preparation |
| JP2690009B2 (en) * | 1986-07-10 | 1997-12-10 | エーザイ 株式会社 | Cefalosporin injection |
| JPH03264531A (en) * | 1990-03-13 | 1991-11-25 | Mochida Pharmaceut Co Ltd | Freeze-dried cephalosporin preparation |
| JPH0459730A (en) * | 1990-06-26 | 1992-02-26 | Dai Ichi Seiyaku Co Ltd | Cephem-based antibiotic-containing lyophilized preparation |
| TW526202B (en) * | 1998-11-27 | 2003-04-01 | Shionogi & Amp Co | Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity |
| CA2444897A1 (en) * | 2001-04-23 | 2002-11-07 | Shionogi & Co., Ltd. | Sulfate of cephem compound |
-
2003
- 2003-06-16 AU AU2003241675A patent/AU2003241675A1/en not_active Abandoned
- 2003-06-16 WO PCT/JP2003/007610 patent/WO2004000323A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004000323A1 (en) | 2003-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003291103A1 (en) | Pharmaceutical composition | |
| AU2003278393A1 (en) | New use for pharmaceutical composition | |
| AU2003290734A1 (en) | Novel compounds as pharmaceutical agents | |
| AU2003302603A1 (en) | Improved opioid pharmaceutical compositions | |
| AU2003282345A1 (en) | Photocurable composition containing maleide derivatives | |
| AU2003250372A1 (en) | Pharmaceutical composition | |
| AU2003301654A1 (en) | Stabilized composition | |
| AU2003245504A1 (en) | Pharmaceutical compositions for drugs having ph-dependentsolubility | |
| AU2002950744A0 (en) | Composition | |
| AU2003252683A1 (en) | Composition for oral use | |
| AU2002952355A0 (en) | Cephem compounds | |
| AU2003291642A1 (en) | Pyrazoloazepine compounds as pharmaceutical agents | |
| AU2003284460A1 (en) | Medicinal composition | |
| AU2003216503A1 (en) | Stable pharmaceutical compositions | |
| AU2003208621A1 (en) | A pharmaceutical composition | |
| AU2003280799A1 (en) | Medicinal composition | |
| AU2003241675A1 (en) | Medicinal cephem compound composition for injection | |
| AU2003251643A1 (en) | Pharmaceutical compositions containing keto-acids for endoperitoneal administration | |
| AU2003238896A1 (en) | Stabilized pharmaceutical compositions containing benzimidazole compounds | |
| AU2003255954A1 (en) | Substituted glycine derivatives for use as medicaments | |
| AU2003280678A1 (en) | Medicinal composition | |
| AU2003227475A1 (en) | Drug containing riboflavin compound | |
| AUPS188302A0 (en) | Pharmaceutical composition | |
| AU2002335161A1 (en) | Medicinal composition | |
| AUPS167102A0 (en) | Pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |